Literature DB >> 34988691

Timing of H3K27me3 loss in secondary anaplastic meningiomas.

Serena Ammendola1, Valeria Barresi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34988691     DOI： 10.1007/s10014-021-00422-1

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN： 1433-7398            Impact factor:   3.154


× No keyword cloud information.
  2 in total

1.  Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.

Authors:  Anna-Katharina Meißner; Robin Gutsche; Norbert Galldiks; Martin Kocher; Stephanie T Jünger; Marie-Lisa Eich; Manuel Montesinos-Rongen; Anna Brunn; Martina Deckert; Christina Wendl; Wolfgang Dietmaier; Roland Goldbrunner; Maximilian I Ruge; Cornelia Mauch; Nils-Ole Schmidt; Martin Proescholdt; Stefan Grau; Philipp Lohmann
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

2.  H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology.

Authors:  Aldo Scarpa; Valeria Barresi; Serena Ammendola; Nicolò Caldonazzi; Michele Simbolo; Maria Liliana Piredda; Matteo Brunelli; Pietro Luigi Poliani; Giampietro Pinna; Francesco Sala; Claudio Ghimenton
Journal:  Virchows Arch       Date:  2021-06-24       Impact factor: 4.535
  2 in total
  1 in total

1.  The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery.

Authors:  Serena Ammendola; Paola Chiara Rizzo; Michele Longhi; Emanuele Zivelonghi; Serena Pedron; Giampietro Pinna; Francesco Sala; Antonio Nicolato; Aldo Scarpa; Valeria Barresi
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.